Abcellera twitter sentiment
Twitter users discuss AbCellera Biologics ($ABCL) surging after post--earnings bounce, with sentiment showing optimism on $655M cash position, fresh insider buying, and ABCL635 advancing to Phase 2 with clean safety profile; commenters expect over 100% upside but anticipate pullback to $4 range for accumulation ahead of Q3 2026 readout.
Sources
- https://x.com/i/status/2057241716197867809
- https://x.com/i/status/2057193976336196084
- https://x.com/i/status/2057246253025743289
- https://x.com/i/status/2057241708749070402
- https://x.com/i/status/2057237127805456651
- https://x.com/i/status/2057242704023822541
- https://x.com/i/status/2057136428367085690
- https://x.com/i/status/2056856843603890506
- https://x.com/i/status/2056202650258116713
- https://x.com/i/status/2057246243118887303
- https://x.com/i/status/2057101134397882741
- https://x.com/i/status/2057235035195937162
- https://x.com/i/status/2057193986822226313
- https://x.com/i/status/2057246815435833609
- https://x.com/i/status/2057193945403171041
- https://x.com/i/status/2056350724272115956
- https://x.com/i/status/2057244849284489328
- https://x.com/i/status/2057087641099583644